Clover Health Investments (NASDAQ: CLOV)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-07 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 814.620M | 846.700M | 32.080M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Clover Health Investments (NASDAQ: CLOV) through any online brokerage.
Other companies in Clover Health Investments’s space includes: Humana (NYSE:HUM), HealthEquity (NASDAQ:HQY), Tekla World Healthcare (NYSE:THW), Molina Healthcare (NYSE:MOH) and Progyny (NASDAQ:PGNY).
The latest price target for Clover Health Investments (NASDAQ: CLOV) was reported by Citigroup on Tuesday, August 9, 2022. The analyst firm set a price target for 3.50 expecting CLOV to rise to within 12 months (a possible 9.03% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Clover Health Investments (NASDAQ: CLOV) is $3.21 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Clover Health Investments.
Clover Health Investments’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Clover Health Investments.
Clover Health Investments is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.